ORTX is currently covered by 4 analysts with average potential upside of $6.21 (73.12%) backed by 21 price targets and 28 ratings. Documented since 26-Nov-2018. Analyst's average stock valuation to be materialised ratio is 20% with an average time for price targets to be met of 70.14 days.
Most recent stock forecast was given by DAVID HOANG from JEFFERIES on 01-Apr-2022.
Highest price target for ORTX is 5, Lowest price target is 1, average price target is 3.
Currently, out of the existing stock ratings of ORTX - 4 which are a Buy (44.44%), 3 which are a Hold (33.33%), 2 which are a Sell (22.22%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
1
$-3.91 (-79.63%)
11 months 26 days ago
1/1 (100%)
$0.23 (29.87%)
343
Hold
1 years 4 months 10 days ago
0/4 (0%)
$8.27 (113.71%)
Buy
17
1 years 4 months 17 days ago
0/3 (0%)
$10.2 (126.62%)
Buy
15
$10.09 (205.50%)
13
2 years 23 days ago
2/5 (40%)
$5 (64.59%)
148
Buy
12
$7.09 (144.40%)
2 years 25 days ago
0/1 (0%)
$4.72 (64.84%)
What is ORTX(Orchard Therapeutics plc) average time for price targets to be met?
Which analyst has the current highest performing score on ORTX(Orchard Therapeutics plc) with a proven track record?
